Helen Tracey Horsley

USPTO Granted Patents = 10 (Patent Applications = 6)

CIPO Patents = 3 (Patent Applications = 8)

EPO Patents = 9 (Patent Applications = 12)

Average Co-Inventor Count = 8.0

ph-index = 2

Forward Citations = 14(Granted Patents)

Company Filing History:

Katholieke Universiteit Leuven, Ku Leuven R&d

6. 1 out of 832,880

Other

patents

where one patent can have more than one assignee

Years Active: 2012-2022

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11472794 - Fused imidazole derivatives as IL-17 modulators (2022-10-18),

2. RE48622 - Therapeutically active pyrazolo-pyrimidine derivatives (2021-07-05),

3. 10980814 - Fused pentacyclic imidazole derivatives as modulators of TNF activity (2021-04-20),

4. 10766906 - Fused hexacyclic imidazole derivatives as modulators of TNF activity (2020-09-08),

5. 10450320 - Hexahydropyrazinotriazinone derivatives as kinase inhibitors (2019-10-22),

6. 10000497 - Fused bicyclic heteroaromatic derivatives as kinase inhibitors (2018-06-19),

7. 9714248 - Therapeutically active pyrazolo-pyrimidine derivatives (2017-07-25),

8. 9550737 - TNF -α modulating benzimidazoles (2017-01-24),

9. 9309243 - Imidazopyridine derivatives as modulators of TNF activity (2016-04-12),

10. 8242116 - Fused thiazole derivatives as kinase inhibitors (2012-08-14),

Title: The Innovative Contributions of Helen Tracey Horsley

Introduction

Helen Tracey Horsley is a distinguished inventor based in Slough, GB. She has made significant contributions to the field of pharmaceuticals, holding a total of 10 patents. Her work primarily focuses on developing novel compounds that address various human ailments, particularly inflammatory and autoimmune disorders.

Latest Patents

Among her latest patents is a series of fused imidazole derivatives that serve as IL-17 modulators. These compounds, including substituted fused bicyclic imidazole derivatives and benzimidazole derivatives, are recognized for their potential in treating and preventing a range of human ailments. Another notable patent involves therapeutically active pyrazolo-pyrimidine derivatives, which are beneficial in addressing inflammatory, autoimmune, and oncological disorders, as well as viral diseases and organ transplant rejection.

Career Highlights

Helen has worked with prominent companies in the pharmaceutical industry, including UCB Biopharma Sprl and UCB Biopharma Srl. Her innovative research and development efforts have positioned her as a key figure in her field.

Collaborations

Throughout her career, Helen has collaborated with notable professionals such as James Thomas Reuberson and Zhaoning Zhu. These partnerships have further enhanced her contributions to the scientific community.

Conclusion

Helen Tracey Horsley exemplifies the spirit of innovation in the pharmaceutical industry through her extensive patent portfolio and collaborative efforts. Her work continues to pave the way for advancements in the treatment of various human ailments.

This text is generated by artificial intelligence and may not be accurate.